Patel Dinesh V Ph D - 16 Jan 2023 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
President and CEO, Director
Signature
/s/ Asif Ali, Attorney-in-Fact for Dinesh V. Patel, Ph.D.
Issuer symbol
PTGX
Transactions as of
16 Jan 2023
Transactions value $
$0
Form type
4
Filing time
18 Jan 2023, 18:48:16
Previous filing
24 Aug 2022
Next filing
02 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTGX Common Stock Gift $0 -3K -0.51% $0.00 581K 04 May 2022 Direct
transaction PTGX Common Stock Gift $0 -3.12K -0.52% $0.00 598K 28 Dec 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTGX Stock Option (right to buy) Award $0 +600K $0.00 600K 16 Jan 2023 Common Stock 600K $12.17 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes an aggregate of 164 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2022.
F2 The stock option vests in 48 equal monthly installments following the date of grant.